Peter Nählstedt has more than 20 years of operational experience from leading positions in life science and industry. His experience includes CEO of Probi AB (publ), Director Europe Trelleborg Marine Systems and General Manager North America BioProcess at GE Healthcare. He has also worked as consultant and advisor and held roles in marketing, sales and strategy at Sigma-Aldrich and GE Healthcare. Today he works as CEO of SenzaGen AB (publ) and is chairman of the board at Supersynbiotics AB and holds board positions at Bio-Works and Optiome AB.
Independence: Independent in relation to the company and the company management, independent in relation to major shareholders.
Shares: 165.000
